Myriad Genetics, Inc. reported goodwill and long-lived asset impairment charges for the first quarter ended March 31, 2022. For the quarter, the company reported Goodwill and long-lived asset impairment charges of $10.7 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.47 USD | +1.30% | +7.10% | +1.72% |
20/03 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
27/02 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.72% | 1.76B | |
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.18B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics, Inc. Reports Goodwill and Long-Lived Asset Impairment Charges for the First Quarter Ended March 31, 2022